| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |